Press release
“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024,” says new Visiongain report
Your guide to your industry
IBD incidence and prevalence is evolving worldwide and is now anticipated to be an emerging global disease. The inflammatory bowel diseases (IBD) drug market will continue to be driven by rising disease incidence and more-effective non-invasive diagnosis.
The lead analyst of the report commented “Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis. Economic development of newly industrialized countries is expected to intensify, and several developing countries will make the transition to the status of newly industrialized countries. The magnitude of the growth of IBD in newly industrialized countries will depend on several factors, including exposure to relevant environmental risk factors, urbanization of the population, access to health care, the speed of adoption of medical technologies such as colonoscopy, and natural population growth. Advances in electronic surveillance of diseases will also enhance reporting of IBD from many regions that currently lack data.”
Purchase full reports or download free sample pages: https://www.visiongain.com/report/global-inflammatory-bowel-diseases-ibd-drug-market-forecast-2019-2029/
Leading companies featured in the report include AbbVie, Allergan, Biogen, Celgene Corporation, Gilead Sciences, Janssen, Novartis, Pfizer, Roche, Takeda, UCB Pharma S.A. and other companies.
Related reports:
• Global Antibacterial Drugs Market 2019-2029: https://www.visiongain.com/report/global-antibacterial-drugs-market-2019-2029/
• Generic Drugs Market Forecast 2019-2029: https://www.visiongain.com/report/generic-drugs-market-forecast-2019-2029/
• Global Human Microbiome Therapeutics Market Forecast 2019-2029: https://www.visiongain.com/report/global-human-microbiome-therapeutics-market-forecast-2019-2029/
For more pharma reports, visit our website: https://www.visiongain.com/industries/pharma/
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987
Visiongain Limited
Airport House
Purley Way
Surrey
London
CR0 0XZ
United Kingdom
About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release “Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024,” says new Visiongain report here
News-ID: 1797641 • Views: …
More Releases from visiongain
Can Coatings Market Research Report Up to 2031
Visiongain has published a new report on Can Coatings Market Report to 2031: Segmentation by Type (Epoxy, Oleoresin, Vinyl, Phenolic, Acrylic, Polyester, Polyolefin, Additives, Other Type) Segmentation by Coating Technologies (Conventional solvent borne coatings, High-solids coatings, Waterborne coatings, Ultraviolet radiation-cured (UV-cured) coatings, Powder coatings, Other Technologies) Segmentation by Application (Food Can, Beverage Can, General Line Can, Aerosol Can, Others, Other Application) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped,…
Automatic Number Plate Recognition (ANPR) System Market Report Up to 2031
Visiongain has published a new report on Automatic Number Plate Recognition (ANPR) System Market Report to 2031: Forecasts by component (Hardware, Software, Services), by type (Fixed ANPR Systems, Portable ANPR Systems), by application (Traffic Management, Law Enforcement, Electronic Toll Collection, Others). PLUS Profiles of Leading Automatic Number Plate Recognition System Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/anpr-system-market/#download_sampe_div
Automatic number plate…
Automatic Labelling Machine Market Report Up to 2031
Visiongain has published a new report on Automatic Labelling Machine Market Report to 2031: Forecasts by type (Stretch Sleeve Labelers, Shrink-Sleeve Labelers, Glue-based Labelers, Others), by industry vertical (Consumer Goods, Food & Beverages, Automotive, Pharmaceuticals, Others). PLUS Profiles of Leading Automatic Labelling Machine Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/automatic-labelling-machine-market/#download_sampe_div
An automatic labeling machine is designed to print-and-apply labels to…
Atomic Absorption Spectrometer Market Report Up to 2031
Visiongain has published a new report on Atomic Absorption Spectrometer Market Report to 2031: Forecasts by type (Х-rау Dіffrасtіоn Ѕресtrоmеtrу, Х-rау Fluоrеѕсеnсе Ѕресtrоmеtrу, Others), by application (Рhаrmасеutісаl, Mining Industry, Petrochemical Industry, Fооd & Веvеrаgе, Others). PLUS Profiles of Leading Atomic Absorption Spectrometer Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/atomic-absorption-spectrometer-market/#download_sampe_div
Atomic absorption spectrometer is the determination of elemental composition and is…
More Releases for IBD
Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An …
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models.
New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies.
Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg
Imaging techniques play a crucial…
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Key Market Highlights
• Crohn's Disease Dominates: Crohn's disease…
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
